Vanessa W. Spingola

Vanessa Spingola practices at Metrolina Infectious Diseases, P.A. in Venice, Florida.

Vanessa Spingola's NPI, 1457947434, was assigned on December 14, 2020. Vanessa Spingola holds Florida license 11010560.

Vanessa Spingola's primary practice is Metrolina Infectious Diseases, P.A., at 219 Palermo Pl, Venice, FL 34285 in Sarasota County. The practice phone is (941) 244-9524.

Vanessa Spingola's primary practice is Metrolina Infectious Diseases, P.A. in Venice, Florida. Vanessa Spingola is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Metrolina Infectious Diseases. Dmand AI also links Vanessa Spingola to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vanessa Spingola practices, 6 sites in all. Vendor and product names are available with a free account.

Family is Vanessa Spingola's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Vanessa Spingola is licensed in Florida.

Dmand AI lists acute skin infection, ankle or foot injury, benign or precancerous skin growths, chronic diabetes, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis and cold sores or genital herpes among the conditions Vanessa Spingola treats.

CMS data shows 942 Medicare services from Vanessa Spingola across 9 procedure codes in 2024, for 532 Medicare patients. Medicare paid $77,094 for them.

CMS counts 532 Medicare patients who saw Vanessa Spingola in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have arthritis, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vanessa Spingola's median patient age at 76, with 46% women.

In 2024, Vanessa Spingola wrote 117 Medicare Part D claims for 49 patients. 96% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $9,255 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Vanessa Spingola for performance year 2024, reported as part of a group. Vanessa Spingola accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vanessa Spingola as offering telehealth.